GxP training services market seen topping $3 billion by 2030

The global good practice, or GxP, training services market is forecast to rise from $1.83 billion in 2025 to $3.08 billion in 2030, according to The Business Research Company. Growth is being driven by tighter regulation, pharma expansion and new digital training tools across regulated industries.

Why it matters: - GxP training is becoming more important as regulated industries face tighter compliance demands and more frequent inspections. - The market's projected growth points to rising spending on workforce training in pharmaceuticals, biotechnology, medical devices and healthcare. - The forecast also signals broader adoption of digital tools tied to compliance, competency tracking and skills development.

What happened: - The Business Research Company released its Good Practice (GxP) Training Services Market Report 2026, covering market size, trends and global forecasts for 2026-2035. - The report says the GxP training services market will grow from $1.83 billion in 2025 to $2.03 billion in 2026. - The market is projected to reach $3.08 billion by 2030. - The report puts the market's compound annual growth rate at 10.8% for 2025-2026 and 11.0% through 2030. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region in the coming years.

The details: - GxP training services are specialized educational programs that teach regulatory standards and quality practices. - The training supports compliance, product quality and safety, data integrity and lower operational and regulatory risk. - The report links historical growth to stricter global compliance requirements, expanded pharmaceutical and biotechnology manufacturing, more inspections, wider use of quality management systems and more standardized workforce training. - The report says future growth will be driven by AI-powered adaptive learning, compliance automation platforms, digital credentialing, predictive compliance analytics and immersive virtual and augmented reality training. - Pharmaceutical manufacturing is a key driver because regulated production requires staff to follow strict protocols, documentation standards and quality controls. - The Institute of Chartered Accountants in England and Wales reported pharmaceutical manufacturing output rose from $22.69 billion (£16.8 billion) in 2022 to $25.66 billion (£19.0 billion) in 2023. - The report covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa in addition to North America and Asia-Pacific. - The 2026 edition includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspot infographics, key technology analysis and future trend analysis. - The report includes a free sample download and a full report link: Download a free sample and View the full report.

Between the lines: - The forecast suggests compliance training is shifting from a back-office requirement to a technology-enabled market category. - The emphasis on AI, analytics and immersive training shows vendors may compete on tools that prove competency, not just deliver content. - Regional growth outside North America points to widening demand as drug development and manufacturing become more global.

What's next: - The market is expected to keep expanding through 2030 as regulated industries scale operations and adopt more automated training systems. - Demand could rise further if clinical trials, manufacturing networks and compliance rules continue to globalize. - The report's focus on future tech suggests the next phase of growth may favor platforms that combine training, monitoring and credentialing in one system.

The bottom line: - GxP training is on track for steady double-digit growth as regulation, manufacturing expansion and digital compliance tools reshape how regulated companies train workers.